- Home
- NDRA vs PSTV Comparison
NDRA vs PSTV Comparison
Compare NDRA & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- PSTV
- Stock Information
- Founded
- NDRA 2007
- PSTV 1996
- Country
- NDRA United States
- PSTV United States
- Employees
- NDRA N/A
- PSTV N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PSTV Medical/Dental Instruments
- Sector
- NDRA Health Care
- PSTV Health Care
- Exchange
- NDRA Nasdaq
- PSTV Nasdaq
- Market Cap
- NDRA 2.1M
- PSTV 2.1M
- IPO Year
- NDRA 2017
- PSTV N/A
- Fundamental
- Price
- NDRA $3.98
- PSTV $0.79
- Analyst Decision
- NDRA Strong Buy
- PSTV Strong Buy
- Analyst Count
- NDRA 1
- PSTV 3
- Target Price
- NDRA $50.00
- PSTV $11.50
- AVG Volume (30 Days)
- NDRA 355.0K
- PSTV 3.8M
- Earning Date
- NDRA 05-13-2025
- PSTV 05-14-2025
- Dividend Yield
- NDRA N/A
- PSTV N/A
- EPS Growth
- NDRA N/A
- PSTV N/A
- EPS
- NDRA N/A
- PSTV N/A
- Revenue
- NDRA N/A
- PSTV $5,824,000.00
- Revenue This Year
- NDRA N/A
- PSTV $13.26
- Revenue Next Year
- NDRA N/A
- PSTV $24.59
- P/E Ratio
- NDRA N/A
- PSTV N/A
- Revenue Growth
- NDRA N/A
- PSTV 18.54
- 52 Week Low
- NDRA $2.97
- PSTV $0.24
- 52 Week High
- NDRA $665.00
- PSTV $2.67
- Technical
- Relative Strength Index (RSI)
- NDRA 51.65
- PSTV 47.37
- Support Level
- NDRA $3.28
- PSTV $0.61
- Resistance Level
- NDRA $3.98
- PSTV $1.22
- Average True Range (ATR)
- NDRA 0.92
- PSTV 0.13
- MACD
- NDRA 0.02
- PSTV 0.02
- Stochastic Oscillator
- NDRA 31.76
- PSTV 29.16
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).